Shionogi & Co., Ltd.

General ticker "SGIOF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $4.5B (TTM average)

Shionogi & Co., Ltd. follows the US Stock Market performance with the rate: 24.8%.

Estimated limits based on current volatility of 0.2%: low 15.16$, high 15.23$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-09-30, amount 0.22$ (Y1.45%)
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-03-31 to 2027-03-31

  • 2025-03-31 to 2026-03-31 estimated range: [11.69$, 16.84$]
  • 2026-03-31 to 2027-03-31 estimated range: [11.78$, 17.10$]

Financial Metrics affecting the SGIOF estimates:

  • Positive: with PPE of 8.0 at the end of fiscal year the price was very low
  • Positive: Operating profit margin, % of 35.73 > 18.64
  • Positive: Operating cash flow per share per price, % of 30.24 > 13.24
  • Negative: negative Industry operating cash flow (median)
  • Negative: Industry earnings per price (median), % of 0 <= 0
  • Negative: 0.79 < Interest expense per share per price, % of 1.40
  • Negative: 0 < Inventory ratio change, % of 0.01
  • Positive: Shareholder equity ratio, % of 88.70 > 63.39
  • Positive: Industry inventory ratio change (median), % of -1.45 <= -0.15
  • Negative: Investing cash flow per share per price, % of -17.96 <= -14.38
  • Negative: negative Industry operating income (median)

Similar symbols

Short-term SGIOF quotes

Long-term SGIOF plot with estimates

Financial data

YTD 2023-03-31 2024-03-31 2025-03-31
Operating Revenue ¥426,684.00MM ¥435,081.00MM ¥438,268.00MM
Operating Expenses ¥277,681.00MM ¥281,771.00MM ¥281,665.00MM
Operating Income ¥149,003.00MM ¥153,310.00MM ¥156,603.00MM
Non-Operating Income ¥71,329.00MM ¥44,973.00MM ¥44,147.00MM
Interest Expense ¥4,500.00MM ¥6,701.00MM ¥9,027.00MM
R&D Expense ¥102,392.00MM ¥102,640.00MM ¥108,612.00MM
Income(Loss) ¥220,332.00MM ¥198,283.00MM ¥200,750.00MM
Taxes ¥35,836.00MM ¥37,708.00MM ¥31,215.00MM
Profit(Loss)* ¥184,965.00MM ¥162,030.00MM ¥170,435.00MM
Stockholders Equity ¥1,100,046.00MM ¥1,235,326.00MM ¥1,361,924.00MM
Inventory ¥57,919.00MM ¥64,916.00MM ¥65,477.00MM
Assets ¥1,311,800.00MM ¥1,416,918.00MM ¥1,535,349.00MM
Operating Cash Flow ¥177,867.00MM ¥154,284.00MM ¥195,460.00MM
Capital expenditure ¥37,187.00MM ¥28,267.00MM ¥52,103.00MM
Investing Cash Flow ¥-48,292.00MM ¥5,922.00MM ¥-116,080.00MM
Financing Cash Flow ¥-84,123.00MM ¥-126,853.00MM ¥-64,908.00MM
Earnings Per Share** ¥621.31 ¥558.32 ¥600.98

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.